NTV Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

NTV Asset Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$636K	Buy	5,819 +104	+2%	+$10.8K	0.06%	197
2026 Q1	$594K	Buy	5,715 +14	+0.2%	+$1.49K	0.07%	194
2025 Q4	$588K	Buy	5,701 +599	+12%	+$58.3K	0.06%	189
2025 Q3	$461K	Sell	5,102 -2,855	-36%	-$250K	0.05%	211
2025 Q2	$700K	Sell	7,957 -1,215	-13%	-$105K	0.08%	165
2025 Q1	$836K	Buy	9,172 +1,463	+19%	+$132K	0.11%	134
2024 Q4	$665K	Buy	7,709 +271	+4%	+$24.5K	0.09%	153
2024 Q3	$707K	Buy	7,438 +341	+5%	+$32.4K	0.09%	149
2024 Q2	$649K	Buy	7,097 +2,102	+42%	+$188K	0.09%	150
2024 Q1	$453K	Buy	+4,995	New	+$437K	0.07%	174
2023 Q1	–	Sell	-2,600	Closed	-$202K	–	254
2022 Q4	$202K	Buy	+2,600	New	+$192K	0.04%	240
2016 Q4	–	Sell	-4,850	Closed	-$278K	–	158
2016 Q3	$278K	Sell	4,850 -800	-14%	-$48K	0.1%	145
2016 Q2	$331K	Sell	5,650 -300	-5%	-$17.5K	0.13%	132
2016 Q1	$342K	Hold	5,950	–	–	0.13%	134
2015 Q4	$388K	Hold	5,950	–	–	0.15%	128
2015 Q3	$374K	Hold	5,950	–	–	0.12%	154
2015 Q2	$420K	Buy	+5,950	New	+$428K	0.12%	153

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

NTV Asset Management's PPH Position: Q2 2026 in Review

NTV Asset Management increased its VanEck Pharmaceutical ETF (PPH) stake by 1.8% in Q2 2026, buying an estimated $10.8K and bringing the position to 5,819 shares worth $636K. The position accounts for 0.06% of the portfolio, ranked #197.

NTV Asset Management first reported a position in PPH in Q2 2015 and has held it in 17 quarters since. The position peaked at $836K in Q1 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

NTV Asset Management held 5,819 shares of VanEck Pharmaceutical ETF worth $636K as of Q2 2026.
NTV Asset Management bought 104 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $10.8K.
VanEck Pharmaceutical ETF made up 0.06% of NTV Asset Management's portfolio in Q2 2026, its #197 holding.
NTV Asset Management first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and has held it in 17 quarters since.
NTV Asset Management's VanEck Pharmaceutical ETF position peaked at $836K in Q1 2025.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on NTV Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.